Tamoxifen lowered breast cancer rates among high-risk women
Tamoxifen lowered breast cancer rates among high-risk women
Reducing fat intake reduces death rates in some breast cancer patients
Recurrence risk could be predicted by a multigene test in ductal carcinoma breast cancer
Breast cancer in men and women has different biological characteristics and outcomes
PD-1 inhibitor pembrolizumab shows promising clinical activity for triple-negative breast cancer
Adding ultrasound to routine mammography improves cancer detection in dense breasts
High tumour immune cell levels may help screen HER2-positive breast cancer patients for chemo
CLL at ASH 2014: Expert discussion
BOLERO-1 reports HER2-positive breast cancer latest PFS data
Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype
Multigene test can predict risk of disease recurrence for women with ductal carcinoma in situ
Examining cell-free DNA provides non-invasive detection of malignancies in Hodgkin lymphoma